A study for a 66 year old woman who takes Calcium, Xarelto, Evista - from FDA reports


Summary

557 females aged 66 (±5) who take the same drugs are studied. This is a personalized study for a 66 year old female patient who has Osteoporosis. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 12, 2017

557 females aged 66 (±5) who take Calcium, Xarelto, Evista are studied.


Number of reports submitted per year:

Calcium, Xarelto, Evista for a 66-year old woman.

Information of the patient in this study:

  • Age: 66
  • Gender: female
  • Conditions: Osteoporosis
  • Drugs taken:
    • Calcium (calcium)
    • Xarelto (rivaroxaban)
    • Evista (raloxifene hydrochloride)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Hair Loss In Women: 0 (0% of females aged 66 (±5) who take the drugs)
  • Heart Palpitations: 4 (0.72% of females aged 66 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • gastrointestinal haemorrhage
  • gingival bleeding
  • haematoma
  • rectal haemorrhage
  • pneumonia
  • sepsis
  • renal haemorrhage
  • haemothorax
  • lower extremity mass
  • head injury
1 - 6 months:
  • gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • rectal haemorrhage
  • nosebleed
  • fatigue
  • productive cough
  • gingival bleeding
  • haemorrhage subcutaneous
  • sepsis
  • hyponatremia
6 - 12 months:
  • gastrointestinal haemorrhage
  • insomnia
  • haemorrhage
  • nosebleed
  • rashes
  • near drowning
  • haemorrhage subcutaneous
  • anaemia
  • haemorrhagic transformation stroke
  • haemorrhagic arteriovenous malformation
1 - 2 years:
  • haemorrhagic anaemia
  • post procedural haematoma
  • anaemia
  • hypovolaemic shock
  • oedema peripheral
  • postmenopausal haemorrhage
  • thrombocytopenia
  • pulmonary embolism
  • pneumonia
  • body height decreased
2 - 5 years:
  • gastrointestinal haemorrhage
  • iron deficiency anaemia
  • rectal haemorrhage
  • acute kidney failure
5 - 10 years:
  • insomnia
  • visual disturbance
  • skin blushing/flushing
  • musculoskeletal stiffness
  • nasal congestion
  • muscle aches
  • vaginal haemorrhage
  • taste - impaired
  • joint pain
  • bone pain
10+ years:
  • joint swelling
  • pain
  • muscle spasms
  • uterine enlargement
  • diarrhea
  • lump in the abdomen
  • stress and anxiety
  • sleep disorder
  • limb discomfort
  • gastrointestinal haemorrhage
not specified:
  • gastrointestinal haemorrhage
  • weakness
  • nausea
  • weight increased
  • hair loss
  • fall
  • fatigue
  • drug ineffective
  • dizziness
  • headache

Top conditions involved for these people *:

  • Stroke (65 people, 11.67%)
  • High Blood Pressure (37 people, 6.64%)
  • Gastroesophageal Reflux Disease (28 people, 5.03%)
  • High Blood Cholesterol (27 people, 4.85%)
  • Rheumatoid Arthritis (23 people, 4.13%)

Top co-used drugs for these people *:

  • Vitamin D (101 people, 18.13%)
  • Fish Oil (60 people, 10.77%)
  • Vitamin E (52 people, 9.34%)
  • Lipitor (45 people, 8.08%)
  • Synthroid (44 people, 7.90%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Evista, Xarelto, Heart palpitations, Calcium, Hair loss in women, Osteoporosis

You may be interested in these reviews

More reviews for: Evista, Xarelto, Heart palpitations, Calcium, Hair loss in women, Osteoporosis